Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Possis' new AngioJet catheter tackles chronic clots

This article was originally published in Clinica

Executive Summary

Possis Medical has gained US go-ahead to sell a new version of its AngioJet catheter that can remove chronic clots more efficiently in larger vessels. The 6Fr DVX peripheral catheter can be used to break apart and remove thrombus from leg arteries greater than or equal to 3mm in diameter. It features a redesigned tip that creates an enhanced and enlarged circulation pattern, resulting in significantly higher thrombus removal rates, explained Possis. The Minneapolis, Minnesota firm said that as the company moved forward to explore the potential treatment of acute deep vein thrombosis in fiscal 2006, it is likely that the DVX catheter would be the "preferred investigational device for any clinical studies".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055103

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel